Waverley Pharma Inc (WAVE)

TSXV
0.0600
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.0400/0.0600
  • Day's Range:
    0.0400 - 0.0600

WAVE Overview

Prev. Close
0.05
Day's Range
0.04-0.06
Revenue
1.69M
Open
0.04
52 wk Range
0.03-0.115
EPS
-0.015
Volume
0
Market Cap
3.24M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
18,346
P/E Ratio
-2.67
Beta
1.5
1-Year Change
-50%
Shares Outstanding
54,000,000
Next Earnings Date
-
What is your sentiment on Waverley Pharma?
or
Market is currently closed. Voting is open during market hours.

Waverley Pharma Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Waverley Pharma Inc Analysis

Waverley Pharma Inc Company Profile

Waverley Pharma Inc Company Profile

Employees
0
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA94357L1058
  • CUSIP:94357L105

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the United Kingdom, European Union, and North America. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising capecitabine, temozolomide, and erlotinib. Its products under development include injectable generic chemotherapy drugs, such as Pemetrexed for the treatment of non-small cell lung cancer and pleural mesothelioma; and Bortezomib to treat multiple myeloma and mantle cell lymphoma. The company has a collaboration agreement with the University of Manitoba for the development of a synthetic library of chloroquine analogs to treat COVID-19. Waverley Pharma Inc. is headquartered in Winnipeg, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralNeutralNeutralStrong Sell
Technical IndicatorsBuySellSellBuyStrong Sell
SummaryBuyNeutralNeutralNeutralStrong Sell